About   Help   FAQ
Mammalian Phenotype Ontology Annotations
Query Results - Summary
Symbol
Name
ID 		Gnas
GNAS complex locus
MGI:95777
210 phenotypes from 18 alleles in 32 genetic backgrounds
Export: Excel File
Allelic Composition
Genetic Background		 Annotated Term Reference
Gnas/Nespastm1.1Jop/Gnas+
involves: 129S1/Sv * M. spretus 		abnormal DNA methylation J:171195
Gnas/Nespastm1.1Jop/Gnas+
involves: 129S/SvEv * 129S1/Sv 		abnormal DNA methylation J:171195
Gnas/Nespastm2.1Jop/Gnas+
involves: 129S/SvEv * 129S1/Sv 		abnormal DNA methylation J:171195
GnasOedsml/Gnas+
involves: 101/H * C3H/HeH 		abnormal coat appearance J:65007
abnormal imprinting J:65007
abnormal inflammatory response J:65007
decreased body weight J:65007
hydrops fetalis J:65007
increased brown adipose tissue amount J:65007
postnatal growth retardation J:65007
postnatal lethality, complete penetrance J:65007
prenatal lethality, incomplete penetrance J:65007
respiratory distress J:65007
small heart J:65007
GnasOedsml/Gnas+
involves: 101/H * C3H/HeH * M. m. castaneus 		hydrops fetalis J:65007
postnatal lethality, complete penetrance J:65007
GnasOedsml/Gnas+
Not Specified 		decreased birth body size J:91717
decreased circulating calcium level J:91717
decreased heart weight J:91717
edema J:91717
increased circulating parathyroid hormone level J:91717
increased circulating phosphate level J:91717
GnasOedsml/GnasOedsml
involves: 101/H * C3H/HeH 		prenatal lethality, complete penetrance J:65007
GnasOedsml/Gnastm1Jop
involves: 129S/SvEv * C57BL/6 		abnormal heart size J:91717
normal homeostasis/metabolism phenotype J:91717
Gnastm1.1Plag/Gnas+
involves: 129S4/SvJae * C57BL/6 * C57BL/6J * SJL 		neonatal lethality, incomplete penetrance J:184320
Gnastm1.1Plag/Gnas+
involves: 129S4/SvJae * C57BL/6 * CD-1 * SJL 		neonatal lethality, incomplete penetrance J:184320
Gnastm1.2Plag/Gnas+
involves: 129S4/SvJae * BALB/cJ * C57BL/6 * CD-1 * SJL 		neonatal lethality, incomplete penetrance J:184320
Gnastm1Gwa/Gnas+
either: (involves: 129S4/SvJae * 129/Sv) or (involves: 129S4/SvJae * C57BL/6J) or (involves: 129S4/SvJae * CD-1) 		decreased alcohol consumption J:70175
Gnastm1Gwa/Gnas+
involves: 129S4/SvJae * C57BL/6J 		abnormal enzyme/coenzyme activity J:70175
impaired righting response J:70175
Gnastm1Gwa/Gnas+
involves: 129S/SvEv * 129S4/SvJae 		abnormal hypodermis morphology J:174525
ectopic bone J:174525
obese J:174525
skin lesions J:174525
Gnastm1Jop/Gnas+
involves: 129S/SvEv * C57BL/6 		no abnormal phenotype detected J:91717
Gnastm1Kel/Gnas+
involves: 129S2/SvPas 		increased circulating ghrelin level J:184320
Gnastm1Kel/Gnas+
involves: 129S2/SvPas * C57BL/6J 		abnormal imprinting J:91703
abnormal suckling behavior J:91703
decreased brown adipose tissue amount J:91703
decreased circulating glucagon level J:91703
decreased circulating glucose level J:91703
decreased circulating insulin level J:91703
decreased interscapular fat pad weight J:91703
decreased locomotor activity J:91703
decreased white adipose tissue amount J:91703
postnatal lethality, complete penetrance J:91703
slow postnatal weight gain J:91703
weakness J:91703
Gnastm1Kel/Gnas+
involves: 129S2/SvPas * C57BL/6J * CD-1 		postnatal lethality J:91703
Gnastm1Lsw/Gnas+
involves: 129S4/SvJae 		decreased urine osmolality J:56867
Gnastm1Lsw/Gnas+
involves: 129S4/SvJae * CD-1 		abnormal blood homeostasis J:106729
abnormal body size J:60971
abnormal brown adipose tissue morphology J:60971
abnormal cerebellar cortex morphology J:49340
abnormal gas homeostasis J:60971
abnormal glucose homeostasis J:106729
abnormal motor capabilities/coordination/movement J:49340
abnormal outer ear morphology J:49340
abnormal posture J:49340
abnormal skin morphology J:49340
absent gastric milk in neonates J:49340
ataxia J:49340
decreased birth body size J:49340
decreased birth weight J:49340
decreased body length J:60971
decreased body mass index J:60971
decreased body weight J:60971
decreased brown adipose tissue amount J:60971
decreased circulating calcium level J:49340
decreased circulating cholesterol level J:60971
decreased circulating glucose level J:106729
decreased circulating insulin level J:106729
decreased circulating triglyceride level J:60971
decreased epididymal fat pad weight J:60971
decreased interscapular fat pad weight J:60971
decreased locomotor activity J:60971
decreased oxygen consumption J:60971
decreased survivor rate J:49340
decreased urine noradrenaline level J:60971
decreased white adipose tissue amount J:60971
delayed kidney development J:49340
genetic imprinting J:49340
normal homeostasis/metabolism phenotype J:60971
impaired balance J:49340
impaired righting response J:49340
improved glucose tolerance J:106729
increased birth body size J:49340
increased birth weight J:49340
increased body mass index J:60971
increased brown adipose tissue amount J:60971
increased brown fat cell lipid droplet size J:60971
increased circulating parathyroid hormone level J:49340
increased insulin sensitivity J:106729
increased interscapular fat pad weight J:60971
increased lean body mass J:49340
increased locomotor activity J:60971
increased muscle cell glucose uptake J:106729
increased oxygen consumption J:60971
increased urine dopamine level J:60971
increased urine noradrenaline level J:60971
increased white adipose tissue amount J:60971
insensitivity to parathyroid hormone J:49340
neonatal lethality, incomplete penetrance J:49340
no spontaneous movement J:49340
obese J:49340
postnatal growth retardation J:49340, J:60971
postnatal lethality, incomplete penetrance J:49340
skin edema J:49340
thymus cortex atrophy J:49340
tremors J:49340
Gnastm1Lsw/Gnastm1Lsw
involves: 129S4/SvJae * CD-1 		prenatal lethality, complete penetrance J:49340
Gnastm2.1Lsw/Gnas+
involves: 129S6/SvEvTac * Black Swiss 		abnormal response/metabolism to endogenous compounds J:97229
decreased circulating parathyroid hormone level J:97229
decreased circulating phosphate level J:97229
maternal imprinting J:97229
Gnastm2.1Lsw/Gnastm2.1Lsw
involves: 129S6/SvEvTac * CD-1 * FVB/N 		normal cellular phenotype J:89923
Gnastm2Jop/Gnas+
involves: 129S/SvEv 		abnormal gas homeostasis J:182868
normal behavior/neurological phenotype J:182868
decreased birth weight J:182868
decreased body length J:182868
decreased bone mineral density J:182868
decreased circulating leptin level J:182868
decreased lean body mass J:182868
decreased percent body fat/body weight J:182868
decreased total body fat amount J:182868
increased basal metabolism J:182868
increased carbon dioxide production J:182868
increased food intake J:182868
increased oxygen consumption J:182868
postnatal lethality, incomplete penetrance J:182868
short femur J:182868
slow postnatal weight gain J:182868
Gnastm2Kel/Gnas+
either: (involves: 129S1/Sv) or (involves: 129S1/Sv * C57BL/6J) 		abnormal response to new environment J:97634
hyperactivity J:97634
normal nervous system phenotype J:97634
paternal imprinting J:97634
Gnastm3Jop/Gnas+
involves: 129S/SvEv 		abnormal eating behavior J:182868
normal behavior/neurological phenotype J:182868
decreased birth weight J:182868
decreased lean body mass J:182868
decreased total body fat amount J:182868
postnatal lethality, incomplete penetrance J:182868
slow postnatal weight gain J:182868
Gnastm3Kel/Gnas+
involves: 129P2/OlaHsd * C57BL/6J * DS/2 		abnormal body weight J:143477
abnormal fat pad morphology J:143477
abnormal imprinting J:143477
paternal imprinting J:143477
postnatal lethality, incomplete penetrance J:143477
Gnastm3Lsw/Gnastm3Lsw
Ren1tm2(cre)Gom/Ren1+
involves: 129S6/SvEvTac * Black Swiss 		abnormal kidney physiology J:118076
abnormal renin activity J:118076
decreased circulating aldosterone level J:118076
decreased circulating renin level J:118076
decreased mean systemic arterial blood pressure J:118076
decreased renal glomerular filtration rate J:118076
decreased urine osmolality J:118076
increased urine prostaglandin level J:118076
Gnastm3Lsw/Gnastm3Lsw
Tg(Col2a1-cre)1Rsjo/0
involves: 129S6/SvEvTac * FVB/N 		abnormal cartilage development J:97230
abnormal long bone epiphyseal plate morphology J:97230
abnormal long bone epiphyseal plate proliferative zone J:97230
abnormal long bone epiphysis morphology J:97230
abnormal pulmonary alveolus morphology J:97230
abnormal tibia morphology J:97230
cyanosis J:97230
domed cranium J:97230
neonatal lethality, complete penetrance J:97230
short limbs J:97230
Gnastm3Lsw/Gnastm3Lsw
Tg(TPO-cre)1Shk/0
involves: 129S6/SvEvTac * FVB/NCr 		normal endocrine/exocrine gland phenotype J:168249
Gnastm4Lsw/Gnas+
involves: 129S6/SvEvTac 		abnormal blood homeostasis J:233851
abnormal kidney morphology J:233851
Gnastm4Lsw/Gnas+
involves: 129S6/SvEvTac * Black Swiss * CD-1 		abnormal adipose tissue morphology J:99237
abnormal glucose homeostasis J:99237
decreased oxygen consumption J:99237
edema J:99237
impaired glucose tolerance J:99237
increased brown adipose tissue amount J:99237
increased circulating glucose level J:99237
increased circulating insulin level J:99237
increased circulating leptin level J:99237
increased circulating triglyceride level J:99237
increased interscapular fat pad weight J:99237
increased total body fat amount J:99237
increased white adipose tissue amount J:99237
insulin resistance J:99237
obese J:99237
paternal imprinting J:99237
postnatal lethality, incomplete penetrance J:99237
Gnastm4Lsw/Gnastm4Lsw
involves: 129S6/SvEvTac * Black Swiss * CD-1 		prenatal lethality J:99237
Gnastm5.1Lsw/Gnastm5.1Lsw
H2az2Tg(Wnt1-cre)11Rth/H2az2+
involves: 129S6/SvEvTac * C57BL/6J * CBA/J 		abnormal bone ossification J:254756
abnormal craniofacial bone morphology J:254756
abnormal craniofacial morphology J:254756
abnormal hyoid bone body morphology J:254756
abnormal hyoid bone morphology J:254756
abnormal incisor morphology J:254756
abnormal mandible morphology J:254756
abnormal maxilla morphology J:254756
abnormal nasal septum cartilage morphology J:254756
abnormal premaxilla morphology J:254756
abnormal suckling behavior J:254756
abnormal sympathetic ganglion morphology J:254756
abnormal thyroid cartilage morphology J:254756
abnormal tongue morphology J:254756
abnormal tympanic ring morphology J:254756
absent mandibular angle J:254756
absent mandibular condyloid process J:254756
absent mandibular coronoid process J:254756
absent nasal capsule J:254756
normal cardiovascular system phenotype J:254756
complete cleft palate J:254756
cyanosis J:254756
domed cranium J:254756
normal embryo phenotype J:254756
mandible hypoplasia J:254756
maxilla hypoplasia J:254756
neonatal lethality, complete penetrance J:254756
normal nervous system phenotype J:254756
ocular hypertelorism J:254756
palatal shelves fail to meet at midline J:254756
palate bone hypoplasia J:254756
premature bone ossification J:254756
premature metopic suture closure J:254756
protruding tongue J:254756
respiratory distress J:254756
round face J:254756
short mandible J:254756
short maxilla J:254756
short snout J:254756
small dorsal root ganglion J:254756
Gnastm5.1Lsw/Gnastm5.1Lsw
Tg(Alb1-cre)1Dlr/?
involves: 129S6/SvEvTac * Black Swiss * FVB/N 		abnormal energy expenditure J:102504
decreased circulating insulin level J:102504
decreased total body fat amount J:102504
normal homeostasis/metabolism phenotype J:102504
hypoglycemia J:102504
improved glucose tolerance J:102504
increased circulating glucagon level J:102504
increased circulating triglyceride level J:102504
increased liver glycogen level J:102504
increased liver weight J:102504
increased pancreas weight J:102504
pancreatic islet hyperplasia J:102504
Gnastm5.1Lsw/Gnastm5.1Lsw
Tg(Fabp4-cre)1Abel/0
involves: FVB 		abnormal adipose tissue development J:159612
abnormal urine catecholamine level J:159612
abnormal white adipose tissue physiology J:159612
decreased body fat mass J:159612
decreased body length J:159612
decreased body size J:159612
decreased body weight J:159612
decreased circulating free fatty acids level J:159612
decreased circulating insulin level J:159612
decreased circulating leptin level J:159612
decreased circulating triglyceride level J:159612
decreased epididymal fat pad weight J:159612
decreased inguinal fat pad weight J:159612
decreased liver triglyceride level J:159612
decreased locomotor activity J:159612
decreased mesenteric fat pad weight J:159612
decreased renal fat pad weight J:159612
decreased skeletal muscle triglyceride level J:159612
decreased subcutaneous adipose tissue amount J:159612
decreased susceptibility to diet-induced obesity J:159612
decreased white adipose tissue amount J:159612
decreased white fat cell size J:159612
normal homeostasis/metabolism phenotype J:159612
hypoglycemia J:159612
impaired adaptive thermogenesis J:159612
improved glucose tolerance J:159612
increased circulating corticosterone level J:159612
increased energy expenditure J:159612
increased fatty acid oxidation J:159612
increased insulin sensitivity J:159612
increased lean body mass J:159612
premature death J:159612
Gnastm5.1Lsw/Gnastm5.1Lsw
Tg(Gfy-cre)1Yyos/?
involves: 129S6/SvEvTac * Black Swiss * C57BL/6J * FVB/N 		normal taste/olfaction phenotype J:233447
Gnastm5.1Lsw/Gnastm5.1Lsw
Tg(Nes-cre)1Atp/0
involves: 129S6/SvEvTac * FVB/N 		normal craniofacial phenotype J:254756
Gnastm5.1Lsw/Gnastm5.1Lsw
Tg(Slc5a2-cre)1Tauc/0
involves: C57BL/6 * DBA/2 		abnormal blood homeostasis J:233851
abnormal urine homeostasis J:233851
decreased circulating calcium level J:233851
decreased vitamin D level J:233851
increased circulating parathyroid hormone level J:233851
Tg(Camk2a-tTA)1Mmay/0
Tg(tetO-Gnas)1593Mpke/0
B6.Cg-Tg(Camk2a-tTA)1Mmay Tg(tetO-Gnas)1593Mpke 		abnormal dorsal striatum morphology J:166114
abnormal spatial learning J:166114
abnormal ventral striatum morphology J:166114
normal behavior/neurological phenotype J:166114
decreased prepulse inhibition J:166114
enhanced long-term potentiation J:166114
enhanced paired-pulse facilitation J:166114
enlarged lateral ventricles J:166114
hyperactivity J:166114
impaired contextual conditioning behavior J:166114
impaired spatial working memory J:166114
Contributing Projects:
Mouse Genome Database (MGD), Gene Expression Database (GXD), Mouse Models of Human Cancer database (MMHCdb) (formerly Mouse Tumor Biology (MTB)), Gene Ontology (GO)
Citing These Resources
Funding Information
Warranty Disclaimer, Privacy Notice, Licensing, & Copyright
Send questions and comments to User Support. 		last database update
11/12/2024
MGI 6.24 		The Jackson Laboratory